Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

RBB Bancorp Announces Upcoming Dividend and ExDividend Date

Elaine Mendonca by Elaine Mendonca
January 26, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

As of January 25, 2024, investors have until Monday to purchase RBB Bancorp (NASDAQ: RBB) stock if they want to be eligible for the upcoming quarterly dividend payout of 16 cents per share. It is important to note that Tuesday marks the ex-dividend date, meaning investors must own the stock before this date to receive the dividend. Shareholders who hold RBB Bancorp stock by the end of Monday’s trading session will qualify for the dividend payout, which is scheduled to be paid out on February 9, 2024.

When it comes to RBB Bancorp’s dividend history, the company has a track record of paying quarterly dividends. Currently, the annual dividend stands at $0.64, resulting in a dividend yield of 3.66%. RBB Bancorp has been distributing dividends since 2017 and boasts a payout ratio of 20.9%, which is lower than the industry average. Looking ahead, the next ex-dividend date falls on Tuesday, with the payment date for the upcoming dividend set for February 9, 2024.

Investors will have the flexibility to decide whether they want to reinvest the dividends back into the stock or utilize the payment in an alternative manner.

RBB Stock Analysis: Resilient Performance and Potential Returns in 2024

On January 25, 2024, RBB stock experienced a slight decline of $0.18 or 0.96% since the market last closed. Despite this drop, the stock closed at $18.48, showcasing resilience. The stock remained unchanged in after-hours trading, indicating stability in the market. RBB stock has been trading near the top of its 52-week range, attracting investors seeking consistent returns. It is also trading above its 200-day simple moving average, indicating a long-term upward trend. While the 0.96% drop may seem significant, it is important to consider the overall context of the stock’s performance. Investors should consider broader market trends, company news, and industry developments when making investment decisions. Monitoring RBB stock’s performance and conducting thorough research can help investors make well-informed decisions to maximize potential returns.

RBB Stock Performance on January 25, 2024: Promising Revenue Growth Amidst Net Income Decline

Title: RBB Stock Performance on January 25, 2024: A Steady Quarter Amidst Revenue Growth

Introduction

On January 25, 2024, RBB (fictional stock) showcased a steady performance, maintaining its revenue growth trajectory despite a slight decline in net income and earnings per share (EPS). This article will analyze RBB’s financial performance based on the data provided, highlighting its total revenue, net income, and EPS trends.

Total Revenue Growth

RBB’s total revenue for the past year stood at $236.13 million, marking a significant increase of 23.3% compared to the previous year. Moreover, the Q4 total revenue of $62.23 million reflects a 6.73% increase since the previous quarter, indicating continued growth momentum.

Net Income Stability

Despite the positive revenue growth, RBB experienced a decline in net income. Over the past year, the company reported a net income of $42.47 million, representing a decrease of 33.95% compared to the previous year. However, the net income held flat at $12.07 million during the fourth quarter, indicating stability in the company’s profitability.

Earnings Per Share Performance

RBB’s earnings per share (EPS) is a crucial metric for investors to assess the company’s profitability on a per-share basis. Over the past year, RBB reported an EPS of $2.24, experiencing a decline of 32.79% compared to the previous year. The EPS remained unchanged at $0.64 during the fourth quarter, signifying a stabilization in the company’s earnings.

Conclusion

RBB’s stock performance on January 25, 2024, showcased promising revenue growth, with a 23.3% increase compared to the previous year. However, RBB experienced a decline in net income and earnings per share, highlighting the need for the company to focus on improving profitability. Investors should closely monitor RBB’s financial performance in subsequent quarters to assess its ability to sustain revenue growth and enhance profitability.

Tags: RBB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Title Deadline Approaching for CSI Compressco Stockholders to Qualify for Dividend Payout

Renewable energy

Barclays Analyst Upgrades Icons Price Target Remains Positive

Government Stock Bull Market

Northern Technologies Announces Quarterly Dividend and ExDividend Date

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com